» Articles » PMID: 29522551

A High-throughput 3' UTR Reporter Screening Identifies MicroRNA Interactomes of Cancer Genes

Overview
Journal PLoS One
Date 2018 Mar 10
PMID 29522551
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Despite the established contribution of deregulated microRNA (miRNA) function to carcinogenesis, relatively few miRNA-cancer gene interactions have been validated, making it difficult to appreciate the true complexity of miRNA-cancer gene regulatory networks.

Results: In this effort, we identify miRNA interactomes of 17 well-established cancer genes, involved in various cancer types, through a miRNome-wide 3' UTR reporter screening. Using a novel and performant strategy for high-throughput screening data analysis, we identify 390 interactions, quadrupling the size of the known miRNA interactome for the cancer genes under investigation. Clear enrichments of established and predicted interactions underscore the validity of the interactome data set. Interactomes appear to be primarily driven by canonical binding site interactions. Nonetheless, non-canonical binding sites, such as offset 6mer and seed-mismatched or G:U wobble sites, also have regulatory activity, albeit clearly less pronounced. Furthermore, we observe enhanced regulation in the presence of 3' supplementary pairing for both canonical and non-canonical binding sites.

Conclusions: Altogether, the cancer gene-miRNA interactome data set represents a unique resource that will aid in the unraveling of regulatory miRNA networks and the dynamic regulation of key protein-coding cancer genes. In addition, it uncovers aspects of the functional miRNA binding site's architecture and the relative contributions of different binding site types.

Citing Articles

Direct lysis of 3D cell cultures for RT-qPCR gene expression quantification.

Gysens F, Ostyn L, Goeteyn E, Blondeel E, Nuyttens J, de Wever O Sci Rep. 2023; 13(1):1520.

PMID: 36707637 PMC: 9883454. DOI: 10.1038/s41598-023-28844-1.


Druggable Biomarkers Altered in Clear Cell Renal Cell Carcinoma: Strategy for the Development of Mechanism-Based Combination Therapy.

Rustum Y, Reis R, Rustum T Int J Mol Sci. 2023; 24(2).

PMID: 36674417 PMC: 9864911. DOI: 10.3390/ijms24020902.


Elucidating miRNA Function in Cancer Biology via the Molecular Genetics' Toolbox.

Azlan A, Rajasegaran Y, Kang Zi K, Rosli A, Yik M, Mohd Yusoff N Biomedicines. 2022; 10(4).

PMID: 35453665 PMC: 9029477. DOI: 10.3390/biomedicines10040915.


The MicroRNA Landscape of MYCN-Amplified Neuroblastoma.

Misiak D, Hagemann S, Bell J, Busch B, Lederer M, Bley N Front Oncol. 2021; 11:647737.

PMID: 34026620 PMC: 8138323. DOI: 10.3389/fonc.2021.647737.


Current perspectives on the dysregulated microRNAs in gastric cancer.

Azarbarzin S, Safaralizadeh R, Khojasteh M, Baghbanzadeh A, Baradaran B Mol Biol Rep. 2020; 47(9):7253-7264.

PMID: 32776162 DOI: 10.1007/s11033-020-05720-z.


References
1.
Ongenaert M, Van Neste L, De Meyer T, Menschaert G, Bekaert S, Van Criekinge W . PubMeth: a cancer methylation database combining text-mining and expert annotation. Nucleic Acids Res. 2007; 36(Database issue):D842-6. PMC: 2238841. DOI: 10.1093/nar/gkm788. View

2.
Helwak A, Kudla G, Dudnakova T, Tollervey D . Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell. 2013; 153(3):654-65. PMC: 3650559. DOI: 10.1016/j.cell.2013.03.043. View

3.
Fabian M, Sonenberg N . The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol. 2012; 19(6):586-93. DOI: 10.1038/nsmb.2296. View

4.
Lewis B, Burge C, Bartel D . Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005; 120(1):15-20. DOI: 10.1016/j.cell.2004.12.035. View

5.
Wu L, Belasco J . Micro-RNA regulation of the mammalian lin-28 gene during neuronal differentiation of embryonal carcinoma cells. Mol Cell Biol. 2005; 25(21):9198-208. PMC: 1265813. DOI: 10.1128/MCB.25.21.9198-9208.2005. View